NL-OMON21382已完成不适用
Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practice.
VU University Medical Center0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Cancer patients starting with capecitabine.
排除标准
- •Younger than 18 years of age or insufficient knowledge of the Dutch language.
研究者
相似试验
已完成
不适用
Adherence and patients’ experiences with erlotinib.CancerOral chemotherapyErlotinibAdherencePlasma concentrationLongkankerOrale chemotherapieErlotinibTherapietrouwPlasmaconcentratieNL-OMON26332VU medical centre, Amsterdam50
已完成
不适用
Adherence and patients’ experiences with oral anticancer agents.cancerNL-OMON21194VU University Medical Center200
已完成
不适用
Adherence and patients' experiences with the use of erlotinib in NSCLC treatment: The influence on plasma concentration and the exploration of factors affecting the use in daily practicenon-small-cell-lung cancer or lung cancer10038666NL-OMON33122Vrije Universiteit Medisch Centrum50
已完成
不适用
Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practicecolorectal cancergastric cancer and breast cancer10017991NL-OMON36444Vrije Universiteit Medisch Centrum90
进行中（未招募）
4 期
A clinical trial of patient adherence and treatment outcome in supervised versus non-supervised artesunate/sulphadoxine - pyrimethamine treatment in uncomplicated falciparum malariaCTRI/2014/10/005105Dr Chiranjib Bagchi Calcutta School of Tropical Medicine62